Successful Treatment of ALK-Positive Large-Cell Neuroendocrine Carcinoma of the Lung With Sequential ALK Inhibitors: A Case Report

ALK-positive large-cell neuroendocrine carcinoma (LCNEC) is an exceptionally rare form of lung cancer. The efficacy of ALK inhibitors in treating ALK-positive LCNEC remains unclear. Here, we report a case of ALK-positive LCNEC of the lung, which revealed a sustained clinical benefit (24+ mo of overa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Takayuki, Uehara, Yuji, Watanabe, Kageaki, Hishima, Tsunekazu, Hosomi, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345342/
https://www.ncbi.nlm.nih.gov/pubmed/37456922
http://dx.doi.org/10.1016/j.jtocrr.2023.100538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345342/
https://www.ncbi.nlm.nih.gov/pubmed/37456922
http://dx.doi.org/10.1016/j.jtocrr.2023.100538

Ejemplares similares